Delivery Order SPE2DR25D1106-SPE2DR26FJS7X
Award Date 3/19/26
Potential Completion Date 3/20/26
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,765.38 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for pharmaceutical supply (Barhemsys 5 mg/2 ml vial, 2 ml quantity). The order is issued under the DLA Troop Support Medical IDC, valued at up to $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...
- <p>The Defense Logistics Agency issued a $6,130.01 delivery order to AmerisourceBergen Drug Corp on March 12, 2026, for Barhemsys 10 mg/4 ml vial pharmaceutical product.</p> <p>The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of March 13, 2026.</p>
- The Defense Logistics Agency issued a $5,735.28 delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Barhemsys 10 mg/4 ml vial pharmaceutical product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,994.83 to AmerisourceBergen Drug Corp for BARHEMSYS 5 mg/2 mL vials on August 18, 2025, with completion targeted for August 19, 2025. This firm fixed-price delivery order, which was not set-aside for small business or other designated groups, represents a competitively awarded transaction supporting federal medical procurement needs. The contractor's corporate office, located in Conshohocken, Pennsylvania, served as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of BARHEMSYS 10 mg/4 ml vials with a ceiling value of $1,285.79. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries an ultimate completion date...
- The Defense Logistics Agency awarded a $1,169.78 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Barhemsys 5 mg/2 ml vial (2 ml units). This firm fixed-price, non-set-aside contract is scheduled for completion by December 4, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense...
- The Defense Logistics Agency awarded a $2,221.96 delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 5 mg/2 ml vials on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication BARHEMSYS 10 MG/4 ML VIAL 4ML. The contract has a ceiling value of $5,316.04 and an ultimate completion date of April 22, 2025. This contract is not designated as a set-aside and represents an open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite...
- The Defense Logistics Agency issued a $1,636.96 delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for pharmaceutical supplies (vial medication, 40 dram, amber). The order was issued under the DLA Troop Support Medical IDC (SPE2DX), valued at $999,999,999.00 through December 2026, which supports global pharmaceutical and medical supply delivery to military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing with an ultimate...
- The Defense Logistics Agency issued a $8,736.06 delivery order to AmerisourceBergen Drug Corp on March 9, 2026, for Benlysta 400 mg vials, with final delivery due March 30, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA....